Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hematologic Neoplasms × monalizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Small Cell Lung Carcinoma 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Leukemia, Myeloid, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Laryngeal Diseases 1 Infections 1 Hematologic Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 COVID-19 1 Breast Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1 Adenocarcinoma Of Esophagus 1

Interventions

Cyclophosphamide 78 fludarabine 66 fludarabine phosphate 42 Tacrolimus 41 Whole-Body Irradiation 38 Mycophenolic Acid 36 Busulfan 31 Melphalan 27 Antilymphocyte Serum 21 thymoglobulin 20 Sirolimus 20 Methotrexate 20 Thiotepa 18 Standard of Care 18 Rituximab 18 venetoclax 17 Stem Cell Transplantation 17 Azacitidine 17 Granulocyte Colony-Stimulating Factor 16 Practice Guidelines as Topic 15 Cytarabine 14 Filgrastim 13 Nivolumab 12 Mesna 12 Bortezomib 12 Peripheral Blood Stem Cell Transplantation 10 Specimen Handling 9 Dexamethasone 9 Cyclosporine 9 Blood Specimen Collection 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02921685 2018-09-19

PIRAT

Institut Paoli-Calmettes

Phase 1 Unknown

Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡